![](/img/cover-not-exists.png)
A Phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
Martin, Thomas, Baz, Rachid, Benson, Don M., Lendvai, Nikoletta, Wolf, Jeffrey, Munster, Pamela, Lesokhin, Alexander M., Wack, Claudine, Charpentier, Eric, Campana, Frank, Vij, RaviLanguage:
english
Journal:
Blood
DOI:
10.1182/blood-2016-09-740787
Date:
May, 2017
File:
PDF, 476 KB
english, 2017